CatalystAlert vs Biocat
Both track biotech catalysts. Biocat Pharma catalyst intelligence for swing traders — a 0–10 quantitative risk/reward score on every FDA decision, PDUFA date and Phase 2/3 readout, built from momentum, short interest, cash runway and event probability. CatalystAlert CatalystAlert is a biotech catalyst intelligence platform tracking FDA decisions, PDUFA dates, and clinical-trial readouts for 1,600+ biotech stocks. Every catalyst date carries a confidence rating — confirmed against an official regulatory source, estimated, or AI-detected — alongside AI entry-timing and a public, scored prediction track record.
| Capability | CatalystAlert | Biocat |
|---|---|---|
| FDA / PDUFA catalyst calendar | ||
| Per-date source-confidence labels | ||
| AI likelihood-of-approval (LOA) | ||
| AI entry-timing (pre-catalyst run-up) | ||
| Quantified per-event trade score | ||
| Institutional / 13F smart-money | ||
| Plain-English trial analysis | ||
| AI portfolio generation | ||
| Public, scored prediction track record | ||
| Free tier |
= verified on the tool's public site · = not advertised / not verified (check their site) · = not offered. Verified 2026-05-31; features & pricing change — confirm on each site. Corrections welcome.
- A single, opinionated 0–10 swing-trade score per catalyst, with a fast score/days-to-event screener.
- Flat pricing with no feature tiers — full access from day one.
- Per-date confidence labels — every catalyst date is marked confirmed (official regulatory source), estimated, or AI-detected, so you know how reliable each date is.
- AI entry-timing — a run-up conviction score for the pre-catalyst window, not just the event date.
- A public, scored prediction track record (likelihood-of-approval, stock-impact, entry-timing) measured against actual outcomes.
- Breadth: 1,600+ biotech & pharma companies and tens of thousands of tracked catalysts.
CatalystAlert: Free tier (calendar, watchlist, weekly digest); Pro $29.99/mo (full calendar, AI predictions, alerts, smart-money); Elite $99.99/mo (API).
Biocat: €19.99/mo, billed monthly, no tiers. Confirm current pricing on their site.
We aim for a fair comparison: details about Biocat were taken from biocat.app on 2026-05-31. If anything is out of date, the source of truth is their own site.
FAQ
Is CatalystAlert a good alternative to Biocat?
CatalystAlert and Biocat both track biotech catalysts (FDA decisions, PDUFA dates, clinical-trial readouts). Biocat is strongest at: a single, opinionated 0–10 swing-trade score per catalyst, with a fast score/days-to-event screener. CatalystAlert adds per-date confidence labels (confirmed / estimated / AI-detected), AI entry-timing for the pre-catalyst run-up, and a public, scored prediction track record. Which fits depends on whether you want Biocat's focus or CatalystAlert's verifiability and entry-timing.
What does CatalystAlert add compared to Biocat?
A public, scored track record so the model is accountable over time, not just a live score. Per-date confidence labels, likelihood-of-approval, and broader company/pipeline coverage.
How much do CatalystAlert and Biocat cost?
CatalystAlert: Free tier (calendar, watchlist, weekly digest); Pro $29.99/mo (full calendar, AI predictions, alerts, smart-money); Elite $99.99/mo (API). Biocat: €19.99/mo, billed monthly, no tiers. Confirm current pricing on their site.
Where do CatalystAlert's catalyst dates come from?
Every catalyst date carries a confidence label: "confirmed" (verified against an official regulatory source), "estimated" (e.g. ClinicalTrials.gov), or "AI-detected" (extracted from news, flagged to verify). Sources include FDA, SEC EDGAR and ClinicalTrials.gov.
See CatalystAlert's catalyst calendar
Sourced FDA & PDUFA dates with confidence labels, AI entry-timing, and a public track record.